Comorbidities and their impact on chronic obstructive pulmonary disease [Kronik obstrüktif akciğer hastal?ğ?nda komorbiditelerin hastal?k üzerine etkileri]

Basit Öğe Kaydı
dc.contributor.authorDursunoğlu N.
dc.contributor.authorKöktürk N.
dc.contributor.authorBaha A.
dc.contributor.authorBilge A.K.
dc.contributor.authorBörekçi Ş.
dc.contributor.authorÇiftçi F.
dc.contributor.authorKaradağ M.G.
dc.contributor.authorKütükçü E.Ç.
dc.contributor.authorNoyan A.
dc.contributor.authorPolatli M.
dc.contributor.authorÖnen Z.P.
dc.contributor.authorSarinç S.
dc.contributor.authorUmut S.
dc.contributor.authorUzaslan E.
dc.contributor.authorÜzüm A.K.
dc.contributor.authorYildiz Ö.A.
dc.contributor.authorTurkish Thoracic Society-COPD Comorbidity Group
dc.date.accessioned2019-10-27T08:21:00Z
dc.date.available2019-10-27T08:21:00Z
dc.date.issued2016
dc.departmentEge Üniversitesien_US
dc.description.abstractChronic obstructive pulmonary disease (COPD) is a complex disease that is associated with devastating outcomes resulting from lung involvement and several comorbidities. Comorbidities could impact on symptomology, quality of life, the complications, the management, economic burden and the mortality of the disease. The importance of comorbidities originates from their impact on the outcome of COPD. The most frequent comorbidities in COPD are cardiovascular, endocrinological, musculoskeletal, phycological disorders and lung cancer. Almost 50% of the COPD patients have 3 or more comorbidities. The recent Global Initiative of Obstructive Lung Disease (GOLD) Guideline suggested proactive search and the treatment of the comorbidities. However, there is no certain evidence demonstrating that active treatment of comorbidities improve the outcomes of COPD. However, it is well known that several comorbidities such as cardiovascular disease and lung cancer have greater impact on mortality caused by COPD. Several studies have shown that Charlson Comorbidity index or more recenty COPD Specific Comorbidity Index (COTE) has been found to be related with mortality of COPD. This concise review intended to summarize the most frequent comorbidities in association with their impact on COPD. © 2016, Ankara University. All rights reserved.en_US
dc.identifier.doi10.5578/tt.2245en_US
dc.identifier.endpage298en_US
dc.identifier.issn0494-1373
dc.identifier.issue4en_US
dc.identifier.pmid28366142en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage289en_US
dc.identifier.urihttps://doi.org/10.5578/tt.2245
dc.identifier.urihttps://hdl.handle.net/11454/25884
dc.identifier.volume64en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAnkara Universityen_US
dc.relation.ispartofTuberkuloz ve Toraksen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectComorbidityen_US
dc.subjectCOPDen_US
dc.titleComorbidities and their impact on chronic obstructive pulmonary disease [Kronik obstrüktif akciğer hastal?ğ?nda komorbiditelerin hastal?k üzerine etkileri]en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu